| Returns | 1W : -0.7% , 1M : 0.9%,1Y : -13.4% |
| Peers & Returns | 1W | 1M | 1Y |
| ABBOTT INDIA | -0.7% | 0.9% | -13.4% |
| SUN PHARMACEUTICAL INDUSTRIES | 2.8% | 10.2% | 40.1% |
| DR REDDYS LABORATORIES | 7.8% | 18.3% | 26.4% |
| DIVIS LABORATORIES | 1.7% | 12% | 63.2% |
| CIPLA | 7.2% | 22.8% | 58.3% |
| BIOCON | -1.4% | 3.4% | 14.3% |
| AUROBINDO PHARMA | 8.5% | 17.7% | 77.9% |
| LUPIN | 5.1% | 6.9% | 28.9% |
| TORRENT PHARMACEUTICALS | 1.5% | 7.8% | 15.5% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
54.09
P/E Calculated based on EPS of 279.04
[ Mar2020 - Standalone Results ] 13.39
P/B Calculated based on Book Value of 1127.54
[ Mar2020 - Standalone Results ] 7.69
P/S Calculated based on Revenues of 4158.52 Cr
[ TTM - Standalone Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
88% 101% 110% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE HEALTHCARE | 3.7% | 15.3% | 56.9% |
| S&P BSE MIDSMALLCAP | 0.2% | 1.7% | 80% |
| S&P BSE MID CAP | -0% | 0.7% | 68.4% |
| S&P BSE LOW VOLATILITY | -0.8% | 1.2% | 41.5% |
| S&P BSE ALLCAP | -0.8% | -0.3% | 59.7% |
| S&P BSE 500 | -0.9% | -0.4% | 58.8% |
| S&P BSE 250 LARGEMIDCAP | -0.9% | -0.4% | 57.2% |
| S&P BSE 200 | -1% | -0.5% | 56.9% |
| S&P BSE LARGE MIDCAP | -1% | -0.7% | 55.6% |
| S&P BSE 100 LARGECAP TMC | -1.1% | -0.7% | 53.9% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY NEXT 50 | -0.1% | 1.6% | 46.2% |
| NIFTY MNC | -0.8% | 0.8% | 31.4% |
| NIFTY 500 | -0.9% | -0.4% | 58.3% |
| NIFTY LARGE MIDCAP 250 | -0.9% | -1.7% | 65% |
| NIFTY 200 | -1% | -0.4% | 55.9% |
| NIFTY 100 | -1.1% | -0.7% | 53.2% |
